MedElevator Войти в исследования
← Поиск публикаций

DOI 10.7554/elife.111980

Медицинская библиотека · eLife · 2026

A membrane-disruptive action of VBIT-4 challenges its role as a widely used VDAC1 oligomerization inhibitor.

Ravishankar Varun, Borges-Araújo Luís, Rajendran Megha, Lafargue Elodie, Byrne Deborah, Buzhinsky Nicolas, Wolfe Mya S, Fitzgerald Wendy, Bautista Nina A, Beyene Bethel G, Larimi Motahareh G, Duneau Jean-Pierre, Sturgis James, Bezrukov Sergey M, Casuso Ignacio, Rostovtseva Tatiana K, Bergdoll Lucie

СтатьяПеревод пока не подготовлен

Аннотация

Voltage-dependent anion channel (VDAC) is the most abundant protein of the mitochondrial outer membrane and a key regulator of metabolite exchange and mitochondrial physiology. Its oligomerization has been proposed to control processes such as mitochondrial DNA release and membrane remodeling, yet the underlying mechanisms remain poorly defined. VBIT-4 has been widely used as a putative inhibitor of VDAC1 oligomerization, despite limited mechanistic validation. Here, using high-speed atomic force microscopy (AFM), we visualized VDAC1 assemblies in lipid membranes and examined the effect of VBIT-4. Unexpectedly, VBIT-4 induced membrane defects and permeabilization at micromolar concentrations, independently of VDAC1. Quantitative AFM analysis further shows that VBIT-4 does not alter VDAC1 cluster organization. Complementary electrophysiology, microscale thermophoresis, and coarse-grained molecular dynamics demonstrate that VBIT-4 partitions into lipid bilayers, increases membrane permeability, and destabilizes membrane structure, without detectable effects on VDAC1 channel properties or assemblies. Consistent with this mechanism, VBIT-4 induces VDAC1-independent cytotoxicity in HeLa cells at concentrations above 10 µM. Together, these results demonstrate that VBIT-4 does not act as a specific inhibitor of VDAC1 oligomerization but instead functions as a membrane-active compound. This work provides a revised framework for interpreting studies using VBIT-4 and highlights the importance of systematically assessing drug-membrane interactions when targeting membrane proteins.

Для цитирования: Ravishankar Varun, Borges-Araújo Luís, Rajendran Megha, Lafargue Elodie, Byrne Deborah, Buzhinsky Nicolas, Wolfe Mya S, Fitzgerald Wendy, Bautista Nina A, Beyene Bethel G, Larimi Motahareh G, Duneau Jean-Pierre, Sturgis James, Bezrukov Sergey M, Casuso Ignacio, Rostovtseva Tatiana K, Bergdoll Lucie. A membrane-disruptive action of VBIT-4 challenges its role as a widely used VDAC1 oligomerization inhibitor.. eLife. 2026. DOI: 10.7554/elife.111980.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.